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Archaeal RadA proteins are close homologues of eukaryal Rad51 and DMC1
proteins and are remote homologues of bacterial RecA proteins. For the repair
of double-stranded breaks in DNA, these recombinases promote a pivotal
strand-exchange reaction between homologous single-stranded and double-
stranded DNA substrates. This DNA-repair function also plays a key role in
the resistance of cancer cells to chemotherapy and radiotherapy and in the
resistance of bacterial cells to antibiotics. A hexameric form of a truncated
Methanococcus voltae RadA protein devoid of its small N-terminal domain
has been crystallized. The RadA hexamers further assemble into two-ringed
assemblies. Similar assemblies can be observed in the crystals of Pyrococcus
furiosus RadA and Homo sapiens DMC1. In all of these two-ringed assemblies
the DNA-interacting L1 region of each protomer points inward towards the
centre, creating a highly positively charged locus. The electrostatic character-
istics of the central channels can be utilized in the design of novel recombinase
inhibitors.
1. Introduction
Bacterial RecA (Clark & Margulies, 1965), archaeal RadA (Sandler
et al., 1996) and eukaryal Rad51 (Shinohara et al., 1992) and DMC1
(Bishop et al., 1992) proteins form a superfamily of recombinases
(alsocalled DNA strand-exchange proteins; Seitz & Kowalczykowski,
2000). Homologous recombination appears to be essential in the
repair of double-stranded DNA breaks and the restarting of stalled
replication forks (Cox, 1998; Cox et al., 2000; Courcelle et al., 2001;
Lusetti & Cox, 2002; Kowalczykowski, 2000). These proteins facilitate
a pivotal DNA strand-exchange process between a single-stranded
DNA (ssDNA) and a homologous double-stranded DNA (dsDNA)
in homologous recombination. Electron-microscopic and crystallo-
graphic results have revealed strikingly similar ‘active’ recombinase
assemblies in the form of right-handed helical ﬁlaments with
approximately six monomers per turn (VanLoock et al., 2003;
Conway et al., 2004; Wu et al., 2004; Chen et al., 2008; Sheridan et al.,
2008; Li et al., 2009a). The milestone structures of Escherichia coli
RecA (EcRecA) in complex with a series of DNA molecules have
shed light on the exact mechanism of homologous DNA strand
exchange (Chen et al., 2008). Crystallized ‘inactive’ ﬁlaments with
shorter helical pitches have also been observed (Story et al., 1992).
Ring-shaped forms with 6–8 protomers have also been commonly
observed by electron microscopy (Heuser & Grifﬁth, 1989; Yu &
Egelman, 1997; Passy et al., 1999; Yang et al., 2001; Galkin et al., 2006;
McIlwraith et al., 2001; Masson et al., 1999). Only heptameric rings of
Pyrococcus furiosus RadA (PfRadA) and octameric Homo sapiens
DMC1 (HsDMC1) have previously been crystallized (Shin et al.,
2003; Kinebuchi et al., 2004). A reconstructed hexameric EcRecA
model has been derived from electron microscopy (Yu & Egelman,
1997). In addition to the three commonly found forms, crystal
structures of overwound three-monomer-per-turn ﬁlaments (Ariza
et al., 2005) and left-handed ﬁlaments of Sulfolobus solfataricus
RadA (SsRadA; Chen et al., 2007; Chang et al., 2009) have also been
observed. Here, we report the ﬁrst crystal structure of hexameric
RadA from Methanococcus voltae devoid of its ﬁrst 60 amino-acidresidues (60MvRadA). Crystal-packing analysis and comparison
with the heptameric PfRadA structure and the octameric HsDMC1
structure indicated that these proteins can form two-ringed assem-
blies.
2. Experimental procedures
2.1. Cloning, protein preparation and crystallization
Theopenreading frameofresidues 61–322 ofRadA fromM.voltae
was inserted between the NdeI and XhoI sites of pET28a (Novagen).
The resulting plasmid was veriﬁed by DNA sequencing using T7
promoter and terminator primers. The recombinant 60MvRadAwas
overexpressed in E. coli BL21 Rosetta2 (DE3) cells (Novagen) at
310 K for 4 h using 0.5 mM isopropyl -d-1-thiogalactopyranoside as
the inducer. The cells were disrupted by sonication. The insoluble
particles were removed by centrifugation at 12 000g. Soluble proteins
were ﬁrst separated by nickel-afﬁnity chromatography. The poly-
histidine tag was then removed by overnight digestion with
1:100(w:w) thrombin (Sigma–Aldrich) at 294 K. Gel-ﬁltration chro-
matography was performed with a Sephacryl S-300 HR column (GE
Healthcare) using a buffer composed of 0.5 M sodium acetate and
30 mM Tris–HCl pH 7.9. The puriﬁed protein was concentrated to
 30 mg ml
 1 by ultraﬁltration.
2.2. Crystallization of D60MvRadA and diffraction data collection
60MvRadAcrystals (space group C2) were grown by the hanging-
drop method and grew to maximum dimensions of 0.4   0.3  
0.2 mm. The optimal well solution consisted of 33% polyethylene
glycol 400, 1.0 M NaNO3,5 0m M MES–NaOH buffer pH 6.7 and
0.06% thymol. A crystal was transferred into the well solution,
looped out of the solution and frozen in a nitrogen cryostream at
100 K. The diffraction data set was collected and processed using
a Bruker PROTEUM R system at the Saskatchewan Structural
Sciences Centre (at a wavelength of 1.5418 A ˚ ). The statistics of the
diffraction data are listed in Table 1.
2.3. Structural determination and refinement
The previously solved RadA model (PDB entry 1t4g; Wu et al.,
2004) was used as the search model for molecular replacement using
Phaser (McCoy et al., 2007). Six monomers were located in the
asymmetric unit, which is consistent with the existence of noncrys-
tallographic sixfold rotational symmetry. The model was iteratively
rebuilt using XtalView (McRee, 1999) and reﬁned using CNS
(Bru ¨nger et al., 1998) and REFMAC (Murshudov et al., 2011).
Statistics of the reﬁnement and model geometry are given in Table 1.
90.6% of nonglycine residues fell in the most favoured region of
the Ramachandran plot. No residues were found in the disallowed
region. The electron-density map was generated by Coot (Emsley &
Cowtan, 2004) and rendered by Raster3D (Bacon & Anderson, 1988).
The ribbon and electrostatic surface ﬁgures were rendered using
CCP4MG (Potterton et al., 2004). C
 traces were generated by
MolScript (Kraulis, 1991) and Raster3D. The coordinates and struc-
ture factors have been deposited in the Protein Data Bank (Bernstein
et al., 1977; Berman et al., 2000, 2003) with code 4dc9.
3. Results
3.1. The overall structure of a hexameric form of D60MvRadA
As in RecA orthologues, a polymerization motif centred at Phe74
contributes to the oligomerization of MvRadA (Wu et al., 2004). In
structural communications
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Table 1
Data-collection and reﬁnement statistics.
Values in parentheses are for the highest resolution shell.
Data collection
Space group C2
Unit-cell parameters (A ˚ ,  ) a = 186.35, b = 118.58, c = 141.73,
 =  = 90,  = 138.05
Resolution (A ˚ ) 39.2–2.60 (2.69–2.60)
Rmerge 0.070 (0.293)
hI/(I)i 8.5 (2.6)
Completeness (%) 90.5 (90.1)
Unique reﬂections 57374 (5768)
Multiplicity 3.6 (3.1)
Reﬁnement
Resolution (A ˚ ) 30–2.6
No. of reﬂections 54446
Rwork/Rfree 0.206/0.266
No. of atoms 12092
Protein 11982
Ligand/ion 48
Water 62
B factors (A ˚ 2) 55.7
Protein 55.7
Ligand/ion 43.8
Water 38.5
R.m.s. deviations
Bond lengths (A ˚ ) 0.013
Bond angles ( ) 1.70
Figure 1
Electron-density map of the P-loop. The ﬁnal -weighted 2Fo   Fc map contoured at 1.2 is shown in stereo. Two putative nitrate-binding sites are also shown. C, N and O
atoms are shown in yellow, blue and red, respectively.structural communications
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Figure 2
Two-ringed assemblies of RadA and DMC1. Ribbon representations are shown in stereo. The ribbons are coloured by chain. (a) 60MvRadA hexamers. Residue 60 of one
subunit is labelled ‘N’. The central sixfold axis is marked by a dark line. (b) PfRadA heptamers. The N-terminal domain of the PfRadA structure is omitted. (c) HsDMC1
octamers.
Figure 3
The conformational changes of MvRadA. Three C
 traces are shown in stereo. The 60MvRadA structure is shown in green, except for its C
 trace from 61 to 75 and from
256 to 285 (magenta). The previously determined ATPase-active ﬁlament of MvRadA is shown in cyan.The 62MvRadA structure inthe inactive ﬁlament is shown inyellow.order to test the effect of this motif on the oligomerization of
MvRadA, we made a series of truncation mutants of MvRadA that
lacked 60–65 N-terminal residues. Similar to the previously studied
62MvRadA (Galkin et al., 2006), 60MvRadA is active in hydro-
lyzing ATP in the presence of poly(dT)36 but inactive in promoting
DNA strand exchange (data not shown). The crystal structure of
60MvRadA was solved by the molecular-replacement method. The
ATP-binding P-loop (residues Gly105–Thr112) was ordered with two
putative nitrate ions (Fig. 1), consistent with the requirement for a
high concentration of sodium nitrate in the crystallization solution.
The peptide chain was largely ordered except for residues 261–268
in the DNA-interacting L2 region (residues Asn256–Arg285). The six
monomers of 60MvRadA formed a closed ring with approximate
sixfold rotational symmetry (Fig. 2a). The central channel is lined by
L1 regions (residues Arg218–Arg230) and has a diameter of 10 A ˚ .
3.2. Two-ringed assembly
Crystal-packing analysis as well as the self-rotation function indi-
cated that the 60MvRadA hexamers further packed into face-to-
face two-ring assemblies with D6 point-group symmetry (Fig. 2a),
with one of the six twofold axes coinciding with the crystallographic
twofold axis. During the gel-ﬁltration stage of the puriﬁcation of the
RadA proteins, the full-length MvRadA as well as the truncated
protein eluted predominantly as a species with a molecular weight of
around 200 kDa. As such, the 60MvRadA protein is likely to exist as
single rings in solution.
3.3. Conformational change of MvRadA
The 60MvRadA protein is composed solely of the conserved
ATPase domain found in RecA orthologues. This domain starts with
structural communications
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Figure 4
Electrostatic properties of RadA and DMC1. The solvent-accessible surfaces of two-ringed assemblies are shown in stereo. The negatively charged area is coloured red,
while the positively charged area is coloured blue. (a) 60MvRadA hexamers. (b) PfRadA heptamers. (c) HsDMC1 octamers.a polymerization motif centred around a hydrophobic residue (Phe64
in MvRadA) which protrudes into a hydrophobic pocket in an
adjacent monomer in the recombinase polymer. In comparison with
the previously determined ATPase-active ﬁlament (104–105 A ˚ pitch)
of MvRadA (PDB entry 2fpm; Wu et al., 2005; Qian et al., 2005) and
the 62MvRadA ﬁlament (PDB entry 2gdj) with a shorter pitch
(91 A ˚ ; Galkin et al., 2006), residues 61–75 showed the most noticeable
translation (Fig. 3). This region also contains a conserved Arg74
residue which has been shown to be important for the conformational
ﬂexibility of RadA and Rad51 (Chen et al., 2007). In all previously
determined ﬁlamentous structures of RadA from M. voltae (Wu et al.,
2004, 2005; Qian et al., 2005, 2006, 2007; Galkin et al., 2006; Li et al.,
2009b) and M. maripaludis (MmRadA; Li et al., 2009a), this Arg74
residue forms a salt bridge with Glu96 (yellow and cyan structures
in Fig. 3). In the hexameric 60MvRadA structure the side chain of
Arg74 was observed in a noticeably different conformation (green
side chain in Fig. 3) that is incapable of retaining the salt bridge.
Two recurrent conformations have been observed in the previously
determined MvRadA and MmRadA helical structures. One (cyan
structure in Fig. 3) is largely ordered except for residues 261–268
in the L2 region and is likely to correspond to the ATPase-active
conformation (Wu et al., 2005). The other (yellow structure in Fig. 3)
is more disordered in the L2 region and is likely to correspond to the
‘inactive’ post-ATP hydrolysis conformation (Qian et al., 2005). The
conformation of each RadA monomer in the hexameric form (green
and magenta structures in Fig. 3) clearly resembles the ATPase-active
form (cyan structure in Fig. 3). A short helix (residues Gly275–
Ala282) was observed in the L2 region which corresponds to helix G
in EcRecA (Story et al., 1992; De Zutter et al., 2001).
3.4. Similar assemblies of PfRadA and HsDMC1
Interestingly, the crystal packing of heptameric PfRadA (Shin et
al., 2003; PDB entry 1pzn) and octameric HsDMC1 (Kinebuchi et al.,
2004; PDB entry 1v5w) suggests that they both form similar two-
ringed assemblies with D7 and D8 point-group symmetry (Figs. 2b
and 2c), respectively. These assemblies resemble the face-to-face
double rings observed for HsDMC1 and SsRadA in the presence of
dsDNA by electron microscopy (Passy et al., 1999; Masson et al., 1999;
Yang et al., 2001). In all such assemblies the L1 regions (residues
Arg218–Arg230 of MvRadA) line a central channel. Each L1 region
has three conserved arginine residues (Arg218, Arg224 and Arg230
in MvRadA) in RadA/Rad51/DMC1 proteins. As a result, the central
channels of such assemblies are highly positively charged (the central
blue regions in Fig. 4).
4. Discussion
Unlike the structures of ﬁlamentous MvRadA, the hexameric
60MvRadA structure revealed a different conformation of Arg74
which is no longer capable of retaining the salt bridge to Glu96. As
such, the crystal structure of 60MvRadA further supports the notion
that the residue equivalent to Arg74 of MvRadA modulates the
conformational changes which give rise to ﬂexibility in the protein
assemblies of orthologous proteins (Chen et al., 2007).
The conformational similarity of 60MvRadA and the ATPase-
active form of MvRadA in the helix G region suggests that this short
helix is inherently stable. In the structures of ﬁlamentous MvRadA
and MmRadA disorder of helix G has been correlated with either the
presence of ADP or the absence of proper cationic bridging between
the C-terminal carbonyl groups of helix G and the -phosphate of the
ATP analogue. This structural feature of 60MvRadA is consistent
with the notion that ATP hydrolysis in recombinase ﬁlaments triggers
disorder ofhelix G and the larger L2 region (Qian et al., 2005; Li et al.,
2009a).
We recently observed that polyanionic compounds such as meta-
tungstate could inhibit MvRadA (Li et al., 2009b) by competing with
DNA for positively charged L1 regions lined along an axial groove in
the MvRadA ﬁlament. Although there is no evidence that such two-
ringed assemblies exist in solution in the absence of DNA, their
highly cationic cavities suggest that anionic compounds that replace
DNA could stabilize such recombinase assemblies and thus inhibit
the formation of active recombinase ﬁlament. It has been discovered
that tumour cells tend to have an elevated level of Rad51 expression,
which correlates with their resistance to radiotherapy and chemo-
therapy (Klein, 2008). Therefore, a Rad51 inhibitor could serve as a
potential adjuvant for cancer therapy. In addition to suppressing the
ATPase activity (Wigle et al., 2006, 2009; Wigle & Singleton, 2007;
Sexton et al., 2010), mimicking the polymerization motif (Cline et al.,
2007) and blocking the DNA-binding groove in the recombinase
ﬁlament (Li et al., 2009b), the two-ringed assemblies of RadA and
DMC1 proteins suggest a fourth strategy for inhibiting the recom-
binase activities of RecA orthologues.
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